Omega Fund Management as of March 31, 2019
Portfolio Holdings for Omega Fund Management
Omega Fund Management holds 13 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gossamer Bio (GOSS) | 48.3 | $151M | 7.0M | 21.67 | |
| Replimune Group (REPL) | 24.8 | $77M | 5.1M | 15.17 | |
| Translate Bio | 8.0 | $25M | 2.4M | 10.19 | |
| Paratek Pharmaceuticals | 4.5 | $14M | 2.6M | 5.36 | |
| Obseva Sa | 4.1 | $13M | 999k | 12.79 | |
| Cymabay Therapeutics | 2.4 | $7.3M | 552k | 13.28 | |
| Fibrogen (FGEN) | 2.3 | $7.1M | 131k | 54.35 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 1.3 | $4.0M | 1.5M | 2.65 | |
| Essa Pharma (EPIX) | 1.2 | $3.7M | 1.1M | 3.41 | |
| Jounce Therapeutics | 1.1 | $3.3M | 530k | 6.20 | |
| Pieris Pharmaceuticals | 0.8 | $2.6M | 778k | 3.35 | |
| Dicerna Pharmaceuticals | 0.8 | $2.4M | 167k | 14.65 | |
| Sienna Biopharmaceuticals (SNNAQ) | 0.6 | $1.8M | 759k | 2.32 |
